Signal Transduction and Targeted Therapy

Signal Transduction and Targeted Therapy

  1. Home
  2. About Journal
  3. Notice to Contributors
  4. Subscription
  5. Contact Us

《Signal Transduction and Targeted Therapy》

Supervisor：The Ministry of Education of the People's Republic of China (MOE)

Sponsor：Sichuan University

Editor-in-chief：Prof. Carlo M. Croce|Prof. Kang Zhang|Prof. Yu-Quan Wei|

Publishing period： Monthly    

ISSN：2095-9907(eISSN 2059-3635)    CN：51-1758/R

Visit the English website

《Signal Transduction and Targeted Therapy》

Supervisor：The Ministry of Education of the People's Republic of China (MOE)

Sponsor：Sichuan University

Editor-in-chief：Prof. Carlo M. Croce|Prof. Kang Zhang|Prof. Yu-Quan Wei|

Publishing period： Monthly

Language： English

ISSN：2095-9907(eISSN 2059-3635)

CN：51-1758/R

Email：sttt@scu.edu.cn

Magazine Introduction

Signal Transduction and Targeted Therapy is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others. Signal Transduction and Targeted Therapy is a multidisciplinary journal, covering topics including but not limited to molecular biology, cell biology, pharmacology, medicinal chemistry, computational chemistry, systems biology, bioinformatics, and clinical medicine. The impact factor of Signal Transduction and Targeted Therapy in 2019 is 13.493.[Details]

Supervisor：The Ministry of Education of the People's Republic of China (MOE)

Sponsor：Sichuan University

Editor-in-chief：Prof. Carlo M. Croce|Prof. Kang Zhang|Prof. Yu-Quan Wei|

Publishing period： Monthly

Language： English

ISSN：2095-9907(eISSN 2059-3635)

CN：51-1758/R

Email：sttt@scu.edu.cn

Magazine Introduction

Signal Transduction and Targeted Therapy is an open access journal, which aims to accomplish timely publication of the latest discoveries and progress in both basic science and clinical research related to signal transduction and targeted therapy. It will include research on major human diseases, such as cancer, autoimmune disorders and others. Signal Transduction and Targeted Therapy is a multidisciplinary journal, covering topics including but not limited to molecular biology, cell biology, pharmacology, medicinal chemistry, computational chemistry, systems biology, bioinformatics, and clinical medicine. The impact factor of Signal Transduction and Targeted Therapy in 2019 is 13.493.[Details]
Article
  • 首页
  • 上一页
  • 下一页
  • 末页